Trends in prevalence, mortality, health care utilization and health care costs of Swiss IBD patients: a claims data based study of the years 2010, 2012 and 2014

Table 3 Percentage of IBD patients with at least one of the listed medical claims (n = 13,451)

%	Total	2010	2012	2014
5-ASA^a	87.4	96.8	84.8	82.2
Immunosuppressants^b	23.2	18.7	24.4	25.9
Biologics^c	9.7	5.3	10.2	12.8
Steroids^d	35.0	32.8	36.5	35.3

ISSN: 1471-230X